Outcome | Limitations | Inconsistency/heterogeneity | Indirectness | Imprecision | Publication bias | Mean difference or OR (95% CI) | No of studies | Certainty of evidence (GRADE) |
3 month ODI Scores | High risk of bias* | High I2 statistic. Clinical heterogeneity present | Not serious | Not serious | Strongly suspected† | −19.90 (−28.24 to 11.57) | 12 Studies (eight observational studies, 4 RCT) | ⊕〇〇〇 Very low |
6 month ODI Scores | High risk of bias* | High I2 statistic. Clinical heterogeneity present | Not serious | Not serious | Strongly suspected† | −11.20 (−14.85 to 7.55) | 15 Studies (10 observational studies, 5 RCT) | ⊕〇〇〇 Very low |
12 month ODI Scores | High risk of bias* | High I2 statistic. Clinical heterogeneity present | Not serious | Not serious | Strongly suspected† | −17.00 (−23.07 to 10.94) | 17 Studies (14 observational studies, 3 RCT) | ⊕〇〇〇 Very low |
24 month ODI Scores | High risk of bias* | High I2 statistic. Clinical heterogeneity present | Not serious | Not serious | Strongly suspected† | −17.11 (−20.88 to 13.34) | Three observational studies | ⊕〇〇〇 Very low |
‘⊕〇〇〇’” reports on level of certainty. The ‘⊕’ means one positive point was given out of four total possible points.
*Most of the observational studies had a high risk of bias in the NOS categories of ‘selection’, ‘comparability of cohorts’, and ‘assessment of outcome’. The RCTs had high risk of bias due to the lack of blinding of participants, personnel, or outcomes.
†Based on Funnel plot and Egger’s test, presence of small sample size studies.
GRADE, Grading of Recommendation, Assessment, Development, and Evaluation; NOS, Newcastle-Ottawa scale; ODI, Oswestry Disability Index; RCTs, randomised controlled trials.